Stonebridge Capital Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21M Sell
85,896
-2,457
-3% -$572K 1.47% 16
2025
Q4
$18.3M Buy
88,353
+1,621
+2% +$321K 1.27% 24
2025
Q3
$16.1M Sell
86,732
-182
-0.2% -$31.2K 1.15% 25
2025
Q2
$13.3M Sell
86,914
-1,148
-1% -$176K 1.01% 33
2025
Q1
$14.6M Sell
88,062
-28,257
-24% -$4.42M 1.19% 28
2024
Q4
$16.8M Buy
116,319
+1,623
+1% +$252K 1.35% 22
2024
Q3
$18.6M Buy
114,696
+2,254
+2% +$359K 1.52% 18
2024
Q2
$16.4M Buy
112,442
+7,272
+7% +$1.08M 1.45% 22
2024
Q1
$16.6M Buy
105,170
+9,556
+10% +$1.52M 1.5% 19
2023
Q4
$15M Buy
95,614
+5,312
+6% +$815K 1.5% 16
2023
Q3
$14.1M Buy
90,302
+4,247
+5% +$701K 1.55% 15
2023
Q2
$14.2M Buy
86,055
+3,836
+5% +$619K 1.51% 15
2023
Q1
$12.7M Buy
82,219
+1,371
+2% +$221K 1.45% 20
2022
Q4
$14.3M Buy
80,848
+1,434
+2% +$248K 1.69% 12
2022
Q3
$13M Buy
79,414
+1,444
+2% +$244K 1.67% 13
2022
Q2
$13.8M Buy
77,970
+1,557
+2% +$277K 1.68% 10
2022
Q1
$13.5M Buy
76,413
+2,414
+3% +$411K 1.46% 13
2021
Q4
$12.7M Buy
73,999
+3,606
+5% +$590K 1.4% 18
2021
Q3
$11.4M Sell
70,393
-62,514
-47% -$10.7M 1.38% 19
2021
Q2
$21.9M Buy
132,907
+68,201
+105% +$11.3M 1.38% 19
2021
Q1
$10.6M Buy
64,706
+4,080
+7% +$660K 1.41% 18
2020
Q4
$9.54M Buy
60,626
+2,697
+5% +$398K 1.44% 17
2020
Q3
$8.63M Buy
57,929
+20
+0% +$2.96K 1.55% 21
2020
Q2
$8.14M Sell
57,909
-1,291
-2% -$188K 1.51% 17
2020
Q1
$7.76M Sell
59,200
-1,203
-2% -$171K 1.64% 12
2019
Q4
$8.81M Buy
60,403
+54
+0.1% +$7.32K 1.44% 17
2019
Q3
$7.81M Sell
60,349
-42
-0.1% -$5.53K 1.35% 20
2019
Q2
$8.41M Sell
60,391
-1,323
-2% -$183K 1.49% 16
2019
Q1
$8.63M Buy
61,714
+4,303
+7% +$576K 1.6% 14
2018
Q4
$7.41M Sell
57,411
-1,579
-3% -$220K 1.73% 16
2018
Q3
$8.15M Buy
58,990
+2,335
+4% +$310K 1.64% 15
2018
Q2
$6.88M Buy
56,655
+1,821
+3% +$227K 1.5% 19
2018
Q1
$7.03M Buy
54,834
+2,067
+4% +$279K 1.62% 14
2017
Q4
$7.37M Sell
52,767
-644
-1% -$89.7K 1.69% 13
2017
Q3
$6.94M Buy
53,411
+1,581
+3% +$210K 1.71% 13
2017
Q2
$6.86M Buy
51,830
+942
+2% +$120K 1.8% 12
2017
Q1
$6.34M Buy
50,888
+140
+0.3% +$16.7K 1.72% 12
2016
Q4
$5.85M Buy
50,748
+2,494
+5% +$288K 1.73% 14
2016
Q3
$5.7M Buy
48,254
+2,049
+4% +$249K 1.78% 13
2016
Q2
$5.61M Sell
46,205
-7,948
-15% -$903K 1.9% 11
2016
Q1
$5.86M Buy
54,153
+998
+2% +$103K 2.06% 12
2015
Q4
$5.46M Buy
53,155
+2,193
+4% +$221K 1.99% 13
2015
Q3
$4.76M Buy
50,962
+13,320
+35% +$1.29M 1.91% 11
2015
Q2
$3.67M Buy
37,642
+3,205
+9% +$321K 1.41% 19
2015
Q1
$3.46M Buy
34,437
+2,989
+10% +$304K 1.34% 19
2014
Q4
$3.29M Buy
31,448
+1,065
+4% +$112K 1.35% 18
2014
Q3
$3.24M Buy
30,383
+1,193
+4% +$124K 1.43% 16
2014
Q2
$3.05M Buy
29,190
+913
+3% +$92.3K 1.38% 19
2014
Q1
$2.78M Buy
28,277
+1,973
+8% +$183K 1.36% 21
2013
Q4
$2.41M Buy
+26,304
New +$2.42M 1.24% 25

Other funds holding JNJ

Stonebridge Capital Advisors's JNJ Position: Q1 2026 in Review

Stonebridge Capital Advisors reduced its Johnson & Johnson (JNJ) stake by 2.8% in Q1 2026, selling an estimated $572K and leaving 85,896 shares worth $21M. The position accounts for 1.47% of the portfolio, ranked #16.

Stonebridge Capital Advisors first reported a position in JNJ in Q4 2013 and has held it in 50 quarters since. The position peaked at $21.9M in Q2 2021. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Stonebridge Capital Advisors held 85,896 shares of Johnson & Johnson worth $21M as of Q1 2026.
  • Stonebridge Capital Advisors sold 2,457 Johnson & Johnson shares in Q1 2026, an estimated $572K.
  • Johnson & Johnson made up 1.47% of Stonebridge Capital Advisors's portfolio in Q1 2026, its #16 holding.
  • Stonebridge Capital Advisors first reported a position in Johnson & Johnson in Q4 2013 and has held it in 50 quarters since.
  • Stonebridge Capital Advisors's Johnson & Johnson position peaked at $21.9M in Q2 2021.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Stonebridge Capital Advisors's 13F filing for Q1 2026, filed 14 May 2026.